Refinement of the Magnetic Resonance Diffusion-Perfusion Mismatch Concept for Thrombolytic Patient Selection: Insights From the Desmoteplase in Acute Stroke Trials.
Stroke. 2012 Jul 3
Shyam Prabhakaran1 and Laurel Smit2
07 Aug 2012
|
Clinical Trial
While controversy persists in whether the mismatch hypothesis should be used in clinical practice, this paper defines a minimum threshold of mismatch volume (MMV) that produced a significant benefit in the extended (3- to 9-hour) treatment window, finding that desmoteplase was beneficial in patients with a large perfusion-weighted...
INDIVIDUAL SUBSCRIPTIONS
Get instant access to Article Recommendations from more than 5,000 expert scientists and clinical researchers, assisted by 5,000 associates, by taking out a monthly subscription. The first month of your subscription will be free of charge.
Start your personal subscription today.
Subscribe for $9.95/monthINSTITUTIONAL SUBSCRIPTIONS
Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.
Recommend to your LibrarianIf you are a librarian or information manager, you may request an extended free trial for your academic or corporate institution.
Request an Institutional Trialyour institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.
If you think you should be able to access this content, please contact us.